Ph 1b: Safety & Immunogenicity of Ad5 Based Oral Norovirus Vaccine

Clinical trial NCT04854746 · COMPLETED

Trial details

NCT number: NCT04854746
Sponsor: Vaxart
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Norovirus Infections

Start date: 2021-04-26
Primary completion: 2022-01-04
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.